The Bcl-2 protein family

Experimental Cell Research

Volumn 256, Issue 1, 2000, Pages 50-57

  Antonsson, Bruno ^a   Martinou, Jean Claude ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

ANIMALIA;

EID: 0034630155     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4839     Document Type: Article

References (68)

1. Tsujimoto Y., Cossman J., Jaffe E., Croce C. Involvement of the bcl-2 gene in human follocular lymphoma. Science. 228:1985;1440-1443.
2. Borner C., Olivier R., Martinou I., Mattmann C., Tschopp J., Martinou J.-C. Dissection of functional domains in Bcl-2 alpha by site-directed mutagenesis. Biochem. Cell Biol. 72:1994;463-469.
3. Yin X.-M., Olivai Z. N., Korsmeyer S. J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:1994;321-323.
4. Farrow S. N., Brown R. New members of the Bcl-2 family and their protein partners. Curr. Opin. Gen. Dev. 6:1996;45-49.
5. Borner C., Martinou I., Mattmann C., Irmler M., Schaerer E., Martinou J.-C., Tschopp J. The protein Bcl-2α does not require membrane attachment, but two conserved domains to suppress apoptosis. J. Cell Biol. 126:1994;1059-1068.
6. L. Nature. 379:1996;554-556.
7. Chittenden T., Flemington C., Houghton A. B., Ebb R. G., Gallo G. J., Elangovan B., Chinnadurai G., Lutz R. J. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14:1995;733-736.
8. Hunter J. J., Parslow T. G. A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J. Biol. Chem. 271:1996;8521-8524.
9. Wang K., Yin X. M., Chao D. T., Milliman C. L., Korsmeyer S. J. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:1996;2859-2869.
10. L and pro-apoptotic activity. J. Biol. Chem. 272:1997;24101-24104.
11. Wang H. G., Miyashita T., Takayama S., Sato T., Torigoe T., Krajewski S., Tanaka S., Hovey L. 3rd, Troppmair J., Rapp U. R. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene. 9:1994;2751-2756.
12. Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 386:1997;728-731.
13. Huang D. C., Adams J. M., Cory S. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J. 17:1998;1029-1039.
14. Cheng E. H., Kirsch D. G., Clem R. J., Ravi R., Kastan M. B., Bedi A., Ueno K., Hardwick J. M. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 278:1997;1966-1968.
15. Grandgirard D., Studer E., Monney L., Belser T., Fellay I., Borner C., Michel M. R. Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J. 17:1998;1268-1278.
16. Reed J. C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
17. L, an inhibitor of programmed cell death. Nature. 381:1996;335-341.
18. Chou J. C., Li H., Salvesen G. S., Yuan J., Wagner G. Solution structure of Bid, an intracellular amplifier of apoptotic signaling. Cell. 96:1999;615-624.
19. McDonnell J. M., Fushman D., Milliman C. L., Korsmeyer S. J., Cowburn D. Solution structure of the proapoptotic molecule Bid: A structural basis for apoptotic agonists and antagonists. Cell. 96:1999;625-634.
20. L and Bcl-2. EMBO J. 16:1997;968-977.
21. Haldar S., Chintapalli J., Croce C. M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56:1996;1253-1255.
22. Roth W., Wagenknecht B., Grimmel C., Dichgans J., Weller M. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. Br. J. Cancer. 77:1998;404-411.
23. Maundrell K., Antonsson B., Magnenat E., Camps M., Muda M., Chabert C., Gillieron C., Boschert U., Vial-Knecht E., Martinou J. C., Arkinstall S. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J. Biol. Chem. 272:1997;25238-25242.
24. L. Cell. 87:1996;619-628.
25. Datta S. R., Dukek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M. E. Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
26. Del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of Bad through the protein kinase Akt. Science. 278:1997;687-689.
27. Harada H., Becknel B., Wilm M., Mann M., Huang L. J.-S., Susan S., Taylor S. S., Scott J. D., Korsmeyer S. J. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell. 3:1999;413-422.
28. Li H., Zhu H., Xu C. J., Yuan J. Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
29. Krajewski S., Tanaka S., Takayama S., Schibler M. J., Fenton W., Reed J. C. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes. Cancer Res. 53:1993;4701-4714.
30. L during apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;3668-3672.
31. Eskes R., Antonsson B., Osen-Sand A., Montessuit S., Richter C., Sadoul R., Mazzei G., Nichols A., Martinou J.-C. Bax-induced cytochrome c release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J. Cell Biol. 143:1998;217-224.
32. L forms an ion channel in synthetic lipid membranes. Nature. 385:1997;353-357.
33. Schendel S. L., Xie Z., Montal M. O., Matsuyama S., Montal M., Reed J. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA. 94:1997;5113-5118.
34. Antonsson B., Conti F., Ciavatta A. M., Montesuit S., Lewis S., Martinou I., Bernasconi L., Bernard A., Mermod J.-C., Mazzei G., Maundrell K., Gambale F., Sadoul R., Martinou J.-C. Inhibition of Bax Channel Forming Activity by Bcl-2. Science. 277:1997;370-372.
35. Lewis S., Bethell S. S., Patel S., Martinou J.-C., Antonsson B. Purification and biochemical properties of soluble recombinant human Bax. Protein Exp. Purif. 13:1998;120-126.
36. Antonsson B., Montessuit S., Lauper S., Eskes R., Martinou J.-C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem. J. 345:2000;271-278.
37. Desagher S., Osen-Sand A., Nichols A., Eskes R., Montessuit S., Lauper S., Maundrell K., Antonsson B., Martinou J.-C. Bid-induced conformational changes of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144:1999;891-901.
38. Eskes R., Desagher S., Antonsson B., Martinou J.-C. Bid Induces the Oligomerization and Insertion of Bax into the Outer Mitochondrial Membrane. Mol. Cell. Biol. 20:2000;929-935.
39. Schendel S. L., Azimov R., Pawlowski K., Godzik A., Kagan B. L., Redd J. C. Ion channel activity of the BH3 only Bcl-2 family member, Bid. J. Biol. Chem. 274:1999;21932-21936.
40. Newmeyer D. D., Farschon D. M., Reed J. C. Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell. 79:1994;353-364.
41. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
42. Rosse T., Olivier R., Monney L., Rager M., Conus S., Fellay I., Jansen B., Borner C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature. 391:1998;496-499.
43. Bossy-Wetzel E., Newmeyer D. D., Green D. R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37-49.
44. Susin S. A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1331-1341.
45. Jürgensmeier J. M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J. C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA. 95:1998;4997-5002.
46. Marzo I., Brenner C., Zamzami N., Sisin S. A., Beutner G., Brdiczka D., Remy R., Xie Z.-H., Reed J. C., Kroemer G. The permeability transition pore complex: A target for apoptosis regulation by caspases and Bcl-2-related proteins. J. Exp. Med. 187:1998;1261-1271.
47. Halestrap A. P., Davidson A. M. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem. J. 268:1990;153-160.
48. Petronilli V., Nicolli A., Costantini P., Colonna R., Bernardi P. Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim. Biophys. Acta. 1187:1994;255-259.
49. Shimizu S., Eguchi Y., Kamiike W., Funahashi Y., Mignon A., Lacronique V., Matsuda H., Tsujimoto Y. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl. Acad. Sci. USA. 95:1998;1455-1459.
50. Kane D. J., Sarafian T. A., Anton R., Hahn H., Gralla E. B., Valentine J. S., Ord T., Bredesen D. E. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
51. Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L., Korsmeyer S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
52. Marzo I., Brenner C., Zamzami N., Jurgensmeier J. M., Susin S. A., Vieira H. L. A., Prevost M.-C., Xie Z., Matsuyama S., Reed J. C., Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:1998;2027-2031.
53. Mancici M., Anderson B. O., Caldwell E., Sedghinasab M., Paty P. B., Hochenbery D. M. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J. Cell. Biol. 138:1997;449-469.
54. Martinou I., Desagher S., Eskes R., Antonsson B., André E., Fakan S., Martinou J.-C. The Release of Cytochrome c from Mitochondria during Apoptosis of NGF-deprived Sympathetic Neurons Is a Reversible Event. J. Cell Biol. 144:1999;883-889.
55. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 399:1999;483-487.
56. Matsuyama S., Xu Q., Velours J., Reed J. C. The Mitochondrial F0F1-ATPase Proton Pump Is Required for Function of the Proapoptotic Protein Bax in Yeast and Mammalian Cells. Mol. Cell. 1:1998;327-336.
57. Veis D. J., Sorenson C. M., Shutter J. R., Korsmeyer S. J. Bcl2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmentated hair. Cell. 75:1993;229-240.
58. Motoyama N., Wang F. P., Roth K. A., Sawa H., Nakayama K., Negishi I., Senju S., Zhang Q., Fujii S., Loh D. Y. Massive cell death in immature hematopoietic cells and neurons in Bcl-X-deficient mice. Science. 267:1995;1506-1510.
59. Print C. G., Loveland K. L., Gibson L., Meehan T., Stylianou A., Wreford N., de Kretser D., Metcalf D., Kontgen F., Adams J. M., Cory S. Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc. Natl. Acad. Sci. USA. 95:1998;12323-12431.
60. Ross A. J., Waymire K. G., Moss J. E., Parlow A. F., Skinner M. K., Russell L. D., MacGregor G. R. Testicular degneration in Bclw-deficient mice. Nat. Genet. 18:1998;251-256.
61. Perez G. I., Knudson C. M., Leykin L., Korsmeyer S. J., Tilly J. L. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat. Med. 3:1997;1228-1232.
62. Dechwerth T. L., Elliott J. L., Knudson C. M., Johnson E. M., Snider W. D., Korsmeyer S. J. Bax is required for neuronal death after tropic factor deprivation and during development. Neuron. 17:1996;401-411.
63. Martinou J. C., Dubois-Dauphin M., Staple J. K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., Huarte J. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
64. Yin X.-M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B., Roth K. A., Korsmeyer S. J. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature. 400:1999;886-891.
65. Bouillet P., Metcalf D., Huang D. C. S., Tarlinton D. M., Kay T. W. H., Kontgen F., Adams J. M., Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1999;1735-1738.
66. Hsu S. Y., Kaipia A., McGee E., Lomeli M., Hsueh A. J. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc. Natl. Acad. Sci. USA. 94:1997;12401-12406.
67. O'Connor L., Strasser A., O'Reilly L. A., Hausmann G., Adams J. M., Cory S., Huang D. C. Bim: A novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17:1998;384-395.
68. Inohara N., Ekhterae D., Garcia I., Carrio R., Merino J., Merry A., Chen S., Nunez G. Mtd, a novel Bcl-2 family member activates apoptosis in the absence of heterodimerization with Bcl-2 and Bcl-XL. J. Biol. Chem. 273:1998;8705-8710.